Roberto M. Lang to Hypertension, Pulmonary
This is a "connection" page, showing publications Roberto M. Lang has written about Hypertension, Pulmonary.
Connection Strength
2.028
-
Three-dimensional echocardiography-based analysis of right ventricular shape in pulmonary arterial hypertension. Eur Heart J Cardiovasc Imaging. 2016 May; 17(5):564-75.
Score: 0.398
-
Right ventricular strain in pulmonary arterial hypertension: a 2D echocardiography and cardiac magnetic resonance study. Echocardiography. 2015 Feb; 32(2):257-63.
Score: 0.371
-
Three-dimensional modeling of the right ventricle from two-dimensional transthoracic echocardiographic images: utility of knowledge-based reconstruction in pulmonary arterial hypertension. J Am Soc Echocardiogr. 2013 Aug; 26(8):860-7.
Score: 0.345
-
Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension. Curr Cardiol Rep. 2012 Jun; 14(3):366-73.
Score: 0.321
-
Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome. Eur Heart J Cardiovasc Imaging. 2017 Jan; 18(1):86-94.
Score: 0.104
-
Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points. Circ Cardiovasc Imaging. 2014 Jan; 7(1):115-24.
Score: 0.089
-
Effect of Optison on pulmonary artery systolic pressure and pulmonary vascular resistance. Am J Cardiol. 2013 Nov 15; 112(10):1657-61.
Score: 0.088
-
The effect of Definity on systemic and pulmonary hemodynamics in patients. J Am Soc Echocardiogr. 2012 May; 25(5):584-8.
Score: 0.079
-
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson. 2012 Feb 01; 14:11.
Score: 0.078
-
Three-dimensional analysis of interventricular septal curvature from cardiac magnetic resonance images for the evaluation of patients with pulmonary hypertension. Int J Cardiovasc Imaging. 2012 Jun; 28(5):1073-85.
Score: 0.075
-
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics. 2008 Apr 22; 33(2):278-91.
Score: 0.060
-
A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease. Am J Respir Crit Care Med. 2012 Aug 15; 186(4):359-68.
Score: 0.020